
BLBD vs RIVN

In the past 12 months, BLBD returned +4% while RIVN lost 4%.
Valuation
Compare price multiples and valuation ratios
| Metric | BLBD | RIVN | Winner |
|---|---|---|---|
P/E Ratio Price to earnings ratio | 6.79 | -4.81 | RIVN |
Forward P/E Forward price to earnings ratio | 0.00 | 0.00 | Tie |
P/S Ratio Price to sales ratio | 1.12 | 3.05 | BLBD |
P/B Ratio Price to book ratio | 3.00 | 3.12 | BLBD |
P/FCF Ratio Price to free cash flow ratio | 11.75 | -5.14 | RIVN |
EV/EBITDA Enterprise value to EBITDA | 22.49 | -9.21 | RIVN |
PEG Ratio Price/earnings to growth ratio | 0.00 | 0.00 | Tie |
Profitability
Compare profit margins and returns on capital
| Metric | BLBD | RIVN | Winner |
|---|---|---|---|
Gross Margin Gross profit margin | 20.6% | 7.5% | BLBD |
Operating Margin Operating profit margin | 11.8% | -60.1% | BLBD |
Net Margin Net profit margin | 17.5% | -55.0% | BLBD |
ROE Return on equity | 76.2% | -67.5% | BLBD |
ROA Return on assets | 24.2% | -21.4% | BLBD |
ROIC Return on invested capital | 19.1% | -30.4% | BLBD |
Growth
Compare revenue and earnings growth rates
| Metric | BLBD | RIVN | Winner |
|---|---|---|---|
Revenue Growth (YoY) Year-over-year revenue growth | 9.9% | 8.4% | BLBD |
Revenue Growth (3Y) 3-year revenue CAGR | 22.7% | 48.1% | RIVN |
Revenue Growth (5Y) 5-year revenue CAGR | 11.0% | 0.0% | BLBD |
EPS Growth (YoY) Year-over-year EPS growth | 22.8% | 34.5% | RIVN |
EPS Growth (3Y) 3-year EPS CAGR | 0.0% | 0.0% | Tie |
EPS Growth (5Y) 5-year EPS CAGR | 63.7% | 0.0% | BLBD |
Balance Sheet & Risk
Compare financial stability and debt levels
| Metric | BLBD | RIVN | Winner |
|---|---|---|---|
Debt/Equity Debt to equity ratio | 0.18 | 1.04 | BLBD |
Current Ratio Current assets to current liabilities | 1.64 | 2.10 | RIVN |
Quick Ratio Quick assets to current liabilities | 0.67 | 1.65 | RIVN |
Interest Coverage EBIT to interest expense | 27.87 | -13.28 | BLBD |
Beta Stock volatility vs market | 1.36 | 1.62 | BLBD |
7211.T
HOG
NFI.TO